Clinical Trials Directory

Trials / Completed

CompletedNCT04772586

Sarcopenia and Mechanical Ventilation in Older Patients Admitted Due to COVID-19

Sarcopenia and Mechanical Ventilation in Older Patient Admitted With COVID-19 Infection

Status
Completed
Phase
Study type
Observational
Enrollment
46 (actual)
Sponsor
Brugmann University Hospital · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The SarcoV study aims at assessing the association between sarcopenia and the indication of mechanical ventilation in older hospitalized patients due to COVID-19 infection

Detailed description

Sarcopenia is disease associated with poor clinical outcomes. In critical ill chirurgical patients, sarcopenia is associated with difficult to wean of mechanical ventilation. The association between sarcopenia and mechanical ventilation is poorly studied in medical patients. COVID-19 pandemic has led a lot of medical patient to be admitted in intensive care units due to acute respiratory failure with need of mechanical ventilation support. The primary objective is to determine if sarcopenia in critically-ill older patients with COVID-19 is associated with the indication of mechanical ventilation. Secondarily, the study aims at determining if sarcopenia is associated with difficult to wean and mortality in critically-ill older patients with COVID-19.

Conditions

Timeline

Start date
2020-09-01
Primary completion
2021-08-20
Completion
2021-08-20
First posted
2021-02-26
Last updated
2022-04-06

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04772586. Inclusion in this directory is not an endorsement.

Sarcopenia and Mechanical Ventilation in Older Patients Admitted Due to COVID-19 (NCT04772586) · Clinical Trials Directory